Andere Sprachen Shield Therapeutics plc

Aktien

Markt geschlossen - London S.E. Andere Börsenplätze 17:35:08 01.05.2024			% 5 Tage	% 1. Jan.
1.75 ^GBX	+29.63%		+22.81%	-73.88%

22.02.	Transcript : Shield Therapeutics plc, 2023 Sales/ Trading Statement Call, Feb 22, 2024
21.02.	FTSE 100 wird vor dem FOMC-Protokoll belastet	AN

EARNINGS AND TRADING: Software Circle & Beximco report higher revenue	30.04.
FTSE 100 takes hit ahead of FOMC minutes	21.02.
Shield Therapeutics sinks as strong performance marred by data issues	21.02.
Shield Therapeutics plc Announces Unaudited Sales Results for the Year Ended 31 December 2023	21.02.
Shield Therapeutics hires former Akili leader as new CFO	09.01.
Shield Therapeutics Names New CFO	09.01.
Shield Therapeutics Appoints Santosh Shanbhag as New CFO, Effective January 16, 2024	09.01.
Comptoir opens restaurant; Intercede wins contract	07.12.
Hardman & Co Research on Shield Therapeutics (STX): Accelerating effectiveness of enlarged sales team	15.11.
Shield to Present Abstract at 26th Annual Women's Healthcare Conference 2023 on Accrufer	23.10.23
FTSE 100 Ends Higher Fueled by Energy Stocks	12.10.23
Shield Therapeutics Chief Financial Officer Rudolf to leave	12.10.23
AIM WINNERS & LOSERS: Windward sees high contracting activity levels	12.10.23
Shield Therapeutics CFO to Step Down	12.10.23
Shield Therapeutics plc Announces Hans-Peter Rudolf Is Standing Down from His Role as Chief Financial Officer on 20 October 2023	12.10.23
Shield Therapeutics' pricing will be "key metric" - Proactive Research Analyst	05.10.23
Shield Therapeutics "couldn't be more pleased" with Viatris collaboration	05.10.23
Aston Martin CEO ups stake; Alkemy's lithium deal	03.10.23
Shield Therapeutics completes USD20 million SWK financing	03.10.23
Shield Therapeutics Closes $20 Million Debt Facility with SWK Funding	03.10.23

Keine Ergebnisse zu dieser Suche